5 questions about the FDA’s fast-track push for psychedelic treatments
Summary
The Food and Drug Administration awarded priority review vouchers to three companies developing psychedelic-based treatments for mental health conditions -- two...
Description
The Food and Drug Administration awarded priority review vouchers to three companies developing psychedelic-based treatments for mental health conditions -- two...
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source